This Thursday, 8 January,
the BPH welcomes Hugues Berry, head of Inserm’s AI division.
Throughout the afternoon, members of our teams will take turns
discussing the role of artificial intelligence in their work.
This is a great opportunity to discuss this new tool in its various applications
and the benefits its use can bring

Renowned expertise in AI and health research

Hugues Berry is head of the AI and Digital Division at Inserm, whose goal is to better integrate artificial intelligence into research.
This division helps researchers and their teams use AI to respond to their needs and find solutions, make data and computing infrastructure more accessible, and share best practices.
Issues and questions related to ethics in the use of AI are at the center of Hugues Berry’s work.

His career path illustrates his recognised expertise:
First as head of modelling in a cell biology laboratory, then as a researcher at Inria, where he was already using computer and mathematical models to study intracellular dynamics through modelling. He subsequently continued to specialise in modelling, but this time in neuroscience.

At Inria, he has held positions such as Deputy Scientific Director for Biology and Digital Health, as well as Vice-President of the Evaluation Committee. He has also contributed to structural programmes such as the PEPR Digital Health programme and led research projects focused on artificial intelligence applications, particularly for drug discovery. Since 2023, he has also been in charge of the Inria AIstroSight project team.

Highly engaged, he currently contributes to several national institutions, including Inserm’s specialised committee for health technologies (CSS7) and the Health Data Hub’s CESREES. At the same time, he serves as section editor (Neurosciences) for the journal PLoS Computational Biology.

On the programme :